Dispensa Group（K7L）株式概要Dispensa Group Plc, a consumer brands company, acquires, integrates, and digitizes food producers. 詳細K7L ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6報酬当社が推定した公正価値より94.5%で取引されている リスク分析German市場と比較して、過去 3 か月間の株価の変動が非常に大きい意味のある時価総額がありません ( €2M )最新の財務報告は6か月以上前のものである すべてのリスクチェックを見るK7L Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.00311.1% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-3m4m2016201920222025202620282031Revenue UK£4.4mEarnings UK£131.0kAdvancedSet Fair ValueView all narrativesDispensa Group Plc 競合他社WASGAU Produktions & HandelsSymbol: DB:MSHMarket cap: €58.1mCopaSymbol: TSE:7689Market cap: JP¥1.1bMediterraSymbol: ATSE:MASTIHAMarket cap: €11.2mIK HOLDINGSLtdSymbol: TSE:2722Market cap: JP¥2.7b価格と性能株価の高値、安値、推移の概要Dispensa Group過去の株価現在の株価€0.00352週高値€0.1252週安値€0.0025ベータ01ヶ月の変化20.00%3ヶ月変化-91.43%1年変化-97.20%3年間の変化n/a5年間の変化n/aIPOからの変化-99.97%最新ニュースお知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdomお知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.New Risk • Feb 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.92m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€7.92m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).New Risk • Jan 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (€18.6m market cap, or US$20.2m).Buying Opportunity • Dec 16Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be €0.046, however this is not to be taken as a buy recommendation but rather should be used as a guide only.最新情報をもっと見るRecent updatesお知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdomお知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.New Risk • Feb 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.92m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€7.92m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).New Risk • Jan 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (€18.6m market cap, or US$20.2m).Buying Opportunity • Dec 16Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be €0.046, however this is not to be taken as a buy recommendation but rather should be used as a guide only.お知らせ • Nov 23Dispensa Group Plc Announces Chief Executive Officer ChangesDispensa Group Plc announced that Mr. Alessandro Colombo is stepping down from his role as Chief Executive Officer for pressing personal reasons and has agreed with the Company that he will leave with immediate effect. Mr. Daniele Besnati has been re-appointed Interim Chief Executive Officer, a role he held immediately prior to Mr. Colombo's appointment. A further announcement regarding a new permanent appointment will be made in due course.Board Change • Oct 31Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Niccolo Caderni was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 20Dispensa Group plc Appoints Alessandro Colombo as CEO with Immediate EffectDispensa Group plc announced the appointment of Mr. Alessandro Colombo as CEO with immediate effect. Mr. Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr. Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr. Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr. Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co. An Italian national, Mr. Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles. Mr. Colombo's current and past directorships are as follows: Past five years: Sonder Italy S.r.l., special attorney (legal representative) from December 10, 2018 until June 30, 2023 Director from October 28, 2019 until November 21, 2019.お知らせ • Aug 24Zamaz plc Announces Board ChangesZamaz plc announced that Dr Niccolò Caderni, previously a Non-Executive Director of the Company, has been appointed Non-Executive Chairman with immediate effect. The previous Chairman, Martin Groak has moved to a Non-Executive Director role and remains as chairman of the Audit Committee.株主還元K7LDE Consumer RetailingDE 市場7D0%1.3%-1.5%1Y-97.2%-21.9%-0.4%株主還元を見る業界別リターン: K7L過去 1 年間で-21.9 % の収益を上げたGerman Consumer Retailing業界を下回りました。リターン対市場: K7Lは、過去 1 年間で-0.4 % のリターンを上げたGerman市場を下回りました。価格変動Is K7L's price volatile compared to industry and market?K7L volatilityK7L Average Weekly Movement36.2%Consumer Retailing Industry Average Movement7.8%Market Average Movement6.0%10% most volatile stocks in DE Market12.9%10% least volatile stocks in DE Market2.7%安定した株価: K7Lの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: K7Lの 週次ボラティリティ は、過去 1 年間で18%から36%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイト2019n/aDaniele Tommaso Besnatiwww.dispensagroup.comもっと見るDispensa Group Plc 基礎のまとめDispensa Group の収益と売上を時価総額と比較するとどうか。K7L 基礎統計学時価総額€2.13m収益（TTM）-€3.06m売上高(TTM)€5.12m0.4xP/Sレシオ-0.7xPER（株価収益率K7L は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計K7L 損益計算書（TTM）収益UK£4.38m売上原価UK£2.63m売上総利益UK£1.76mその他の費用UK£4.37m収益-UK£2.61m直近の収益報告Feb 28, 2023次回決算日該当なし一株当たり利益（EPS）-0.0037グロス・マージン40.06%純利益率-59.63%有利子負債／自己資本比率0%K7L の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/03/21 01:42終値2024/03/21 00:00収益2023/02/28年間収益2022/08/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Dispensa Group Plc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.
お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdom
お知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.
New Risk • Feb 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.92m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€7.92m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).
New Risk • Jan 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (€18.6m market cap, or US$20.2m).
Buying Opportunity • Dec 16Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be €0.046, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
お知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.
お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdom
お知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.
New Risk • Feb 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.92m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€7.92m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).
New Risk • Jan 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (€18.6m market cap, or US$20.2m).
Buying Opportunity • Dec 16Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be €0.046, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
お知らせ • Nov 23Dispensa Group Plc Announces Chief Executive Officer ChangesDispensa Group Plc announced that Mr. Alessandro Colombo is stepping down from his role as Chief Executive Officer for pressing personal reasons and has agreed with the Company that he will leave with immediate effect. Mr. Daniele Besnati has been re-appointed Interim Chief Executive Officer, a role he held immediately prior to Mr. Colombo's appointment. A further announcement regarding a new permanent appointment will be made in due course.
Board Change • Oct 31Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Niccolo Caderni was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 20Dispensa Group plc Appoints Alessandro Colombo as CEO with Immediate EffectDispensa Group plc announced the appointment of Mr. Alessandro Colombo as CEO with immediate effect. Mr. Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr. Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr. Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr. Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co. An Italian national, Mr. Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles. Mr. Colombo's current and past directorships are as follows: Past five years: Sonder Italy S.r.l., special attorney (legal representative) from December 10, 2018 until June 30, 2023 Director from October 28, 2019 until November 21, 2019.
お知らせ • Aug 24Zamaz plc Announces Board ChangesZamaz plc announced that Dr Niccolò Caderni, previously a Non-Executive Director of the Company, has been appointed Non-Executive Chairman with immediate effect. The previous Chairman, Martin Groak has moved to a Non-Executive Director role and remains as chairman of the Audit Committee.
